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Abstract
Comprehensive analysis of alterations in gene expression along with neoplastic transforma-
tion in human cells provides valuable information about the molecular mechanisms underly-
ing transformation. To further address these questions, we performed whole transcriptome
analysis to the human mesenchymal stem cell line, UE6E7T-3, which was immortalized
with hTERT and human papillomavirus type 16 E6/E7 genes, in association with progress of
transformation in these cells. At early stages of culture, UE6E7T-3 cells preferentially lost
one copy of chromosome 13, as previously described; in addition, tumor suppressor genes,
DNA repair genes, and apoptosis-activating genes were overexpressed. After the loss of
chromosome 13, additional aneuploidy and genetic alterations that drove progressive trans-
formation, were observed. At this stage, the cell line expressed oncogenes as well as genes
related to anti-apoptotic functions, cell-cycle progression, and chromosome instability
(CIN); these pro-tumorigenic changes were concomitant with a decrease in tumor suppres-
sor gene expression. At later stages after prolong culture, the cells exhibited chromosome
translocations, acquired anchorage-independent growth and tumorigenicity in nude mice,
(sarcoma) and exhibited increased expression of genes encoding growth factor and DNA
repair genes, and decreased expression of adhesion genes. In particular, glypican-5
(GPC5), which encodes a cell-surface proteoglycan that might be a biomarker for sarcoma,
was expressed at high levels in association with transformation. Patched (Ptc1), the cell sur-
face receptor for hedgehog (Hh) signaling, was also significantly overexpressed and co-lo-
calized with GPC5. Knockdown of GPC5 expression decreased cell proliferation,
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suggesting that it plays a key role in growth in U3-DT cells (transformants derived from
UE6E7T-3 cells) through the Hh signaling pathway. Thus, the UE6E7T-3 cell culture model
is a useful tool for assessing the functional contribution of genes showed by expression pro-
filing to the neoplastic transformation of human fibroblasts and human mesenchymal stem
cells (hMSC).
Introduction
Neoplastic transformation of human fibroblasts and epithelial cells is thought to result from
the sequential acquisition of genetic and/or epigenetic alterations in specific genes [1]. Much
progress has been made in identifying and characterizing the genetic elements required to
transform normal human cells [2–10]. Collectively, the results of these studies suggest that the
transformation of human cells in vitro depends upon functional alterations in four to six genes.
These alterations include changes in genes involved in telomere maintenance (to extend repli-
cative lifespan), disruption of tumor suppressor pathways, and activation of oncogenes [2–10].
For example, the transformation of normal human fibroblasts requires the co-expression of
MYC, RAS, and hTERT together with the functional loss of the RB, PTEN, and p53 tumor sup-
pressor pathways. However, a review by Duesberg and colleagues suggests that aneuploidy, in
which a cell contains an abnormal number of chromosomes, is the primary cause of, and driv-
ing force behind, tumorigenesis: they state that aneuploidy results in an imbalance of gene ex-
pression, leading to the initiating event that initiates the transformation of normal cells [11].
An alternative explanation for the role of aneuploidy in tumorigenesis comes from mouse
models harboring modifications in mitotic checkpoint genes. Studies of these mice have indi-
cated that those showing reduced expression of mitotic checkpoint components, such as Bub1,
BubR1, CENP-E, and Mad2, display an increased aneuploidy. In some mice, (CENP-E hetero-
zygous mice, for example), reduced levels of CENP-E are associated with an increase in sponta-
neous tumorigenesis [12]. However, mice deficient in several spindle checkpoint–proteins,
including BubR1, Bub1, and Bub3, display significantly increased level of aneuploidy without
any increase in spontaneous tumorigenesis [13–15]. This indicates that even though aneuploi-
dy is common in most human tumors, it is a promoter, rather than an initiator of tumor for-
mation [16].
In addition, it is important to consider that distinct cell types show considerable differences
in their susceptibility to transformation. Chromosomal changes in, or transformation of,
human fibroblasts and hMSCs during culture can be caused not only by the introduction of the
six genetic elements mentioned above, but also by the introduction of hTERT alone [17,18]. In
addition, some hMSCs transduced with the hTERT gene show transformed phenotypes [17],
but some are resistant [2,7,8,19]. Similarly, human embryonic stem cells continue to accumu-
late genetic and chromosomal changes during culture; these changes are similar to those ob-
served in tumors [20]. The connection between genetic alterations and aneuploidy, both of
which may induce transformation, remains unknown. However, the similarity between the
final phenotype shown by different cells (i.e., transformed) suggests that the similar transfor-
mation programs, or an overlapping set of cancer-related genes, are involved.
By contrast, it is less clear how such genetic elements or aneuploids alter subsequent gene
expression patterns influencing the progress of neoplastic transformation. To identify these
genes and/or programs, we undertook a comprehensive analysis of gene expression changes in
Alteration in Gene Expression on Transformation
PLOS ONE | DOI:10.1371/journal.pone.0126562 May 15, 2015 2 / 23
an immortalized hMSC cell line, UE6E7T-3, and associated these changes with the phenotypic
appearance, including chromosomal aberrations, during long-term culture.
Recently, we showed that UE6E7T-3 cells show the preferential loss of one copy of chromo-
some 13 upon prolonged culture, yielding cells with near-diploid aneuploidy [21,22]. However,
at a population doubling level (PDL) of 110, near-diploid aneuploid cells do not display an-
chorage-independent growth. Here, we show that upon prolonged culture, these cells became
near-triploid, began to proliferate at an increased rate, displayed anchorage-independent
growth, and formed fibrosarcoma-like tumors in nude mice. Furthermore, we comprehensively
examined the genetic and chromosomal alterations that might drive the transformation associ-
ated with these phenotypes and found an important factor, GPC5, which was overexpressed
and contributed to cell proliferation at late stage.
Materials and Methods
Cell culture
The human mesenchymal stem cell line UE6E7T-3 (JCRB1136) was obtained from JCRB Cell
Bank (Osaka, Japan), which entailed no ethical problems.
Imabayashi et al. isolated human mesenchymal cells (H4-3) from the bone marrow of a
donor (91 years old, female) [23]. The UE6E7T-3 cell line, which was originally called
‘ThMSC3’, was immortalized from H4-3 cells using LXSN-E6E7 and LXSN-hTERT and depos-
ited into JCRB Cell Bank (http://cellbank.nibio.go.jp/), which verified the quality of the cells.
UE6E7T-3 cells were cultured in POWEREDBY10 medium (GP Biosciences Ltd., Yokohama,
Japan, http://www.gpbio.jp/), as recommended by JCRB Cell Bank. POWEREDBY10 medium
is widely available worldwide and the cells can also be cultured in DMEM containing 10% FBS.
We confirmed that UE6E7T-3 cells also lost one of chromosome 13 in DMEM containing 10%
FBS at near 100 PDL of culture period. Cells were seeded at a concentration of 5×103 cells/ml
and cultured for 6–10 days, as described previously [21]. The population doubling level (PDL)
was calculated as previously reported using the following formula: PDL = log (cell output/
input)/log2 [22]. At the start of cultivation of this study, the PDL of UE6E7T-3 was 60. Further
cultures consist of Stage I (PDL 60–90), Stage II (PDL 91–150), Stage III (PDL 151–230), and
Stage IV (PDL 231–295). These four samples were named U3-A, U3-B, U3-C, and U3-DT, re-
spectively. U3-DT cells (JCRB1136.01) at Stage IV (PDL 260) were deposited into the JCRB
bank; the quality and ethics of the cells were verified by the bank.
Flow cytometry
Cells of Stage I (PDL 65 or 70), Stage II (PDL 92), Stage III (PDL 200) and Stage IV (PDL 252)
were harvested with trypsin and suspended in 5% FBS-PBS at the concentrations of 1–2 x 106
cells/ml. 100 μl of each cell suspension was mixed with 5 μl of antibody diluted to 20 fold with
5% FBS-PBS. After incubation at 4°C for 20 min, cell suspension was washed 2 times with 5%
FBS-PBS and was suspended with 500 μl of 4% paraformaldehyde–PBS. Data acquisition of
10,000 cells was performed using FACSCanto (BD). Analysis was performed using FlowJo soft-
ware (TOMY Digital Biology). Antibodies used in this test were as follows, APC anti-CD34
(555824, BD), FITC anti-CD44 (IM1219U, Immunotech), FITC anti-CD45 (F0861, DAKO),
RPE anti-CD73 (550257, BD), FITC anti-CD90 (F7274, DAKO), and RPE anti-CD105
(A07414, Immunotech). APC IgG1 (X0968, DAKO), FITC IgG1 (X0927, DAKO), RPE IgG1
(X0928, DAKO), and RPE IgG3 (731609, Immunotech) were also used as negative control.
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Measurement of chromosome number and mFISH analysis
Measurement of chromosome number and mFISH analysis were performed as previously de-
scribed [21]. Briefly, for mFISH analysis, metaphase chromosome spreads and the multicolor
probe (mFISH-24Xcyte-kit, MetaSystems GmbH, Jena, Germany) were denatured with 0.07 N
NaOH and hybridized at 37°C for 1–4 d. FISH images were captured and analyzed using a
Zeiss Axio Imager microscope (Carl Zeiss Microimaging GmbH, Jena, Germany) and Isis
mBAND/mFISH imaging software (MetaSystems GmbH).
Anchorage-independent growth (agar colony assay)
Between 125 and 1×105 cells were cultured in POWEREDBY10 medium containing 0.3% aga-
rose (Invitrogen Co.) on 0.6% agarose for 21 days. Colonies of diameter>300 μm (including
>100 cells) were counted [3].
Tumorigenicity assay
Tumorigenicity experiments were performed by subcutaneous (s.c.) or intramuscular injection
(i.m.) of 1×107 U3-DT cells into BALB/cAJcl-nu/nu mice (Clea Japan, Inc., Tokyo, Japan) [24].
The protocols were approved by the Laboratory Animal Care and the Use Committee of the
National Research Institute for Child and Health Development, Tokyo, Japan (approval num-
bers: 2003–002 and 2005–003). In the fourth week, the transplanted tissues were removed and
embedded in paraffin blocks. Standard hematoxylin and eosin staining of paraffin-embedded
tissue was performed for histological examination of tumorigenicity.
cDNA synthesis and whole-transcriptome sequencing
After subconfluent culture, 5×106–1×107 UE6E7T-3 cells at PDL 80 (Stage I), PDL110 (Stage
II), PDL219 (Stage III) and PDL270 (Stage IV) were harvested. Each cellular total RNA from
the four samples was extracted using QIAGEN RNeasy Mini Kit (Qiagen K. K., Tokyo, Japan).
RNA samples were stored at −80°C until use. Poly-A RNA was used to select mRNA using the
SOLiD RiboMinus Kit (Life Technologies, Gaithersburg, MD, USA). Following rRNA deple-
tion, poly-A RNA was used to synthesize cDNA using the SOLiDWhole-Transcriptome Anal-
ysis Kit (Life Technologies) [25]. DNA sequencing (longest 50bp-reads) was carried out using
SOLiD 3 PLUS System (Life Technologies) as described previously [26].
Mapping sequence data and RNA-Seq analysis
SOLiD sequence data were mapped on the NCBI/GenBank Homo sapiens genome sequence
(hg19, http://hgdownload.cse.ucsc.edu/download.html#human). Quality control of these se-
quence data was performed using the CLC Genomics Workbench-v4.5 (CLC bio Japan, Inc.
Tokyo, Japan). At least, 90% length and 80% similarity of the reference gene have been required
in order to carry out the mapping of the sequenced reads to reference genome.
The Genomics Workbench yields gene expression values in units of “reads per kilobase of
exon model per million mapped reads" (RPKM)
[27]. All sequence reads have been deposited to the DDBJ database of the National Institute
of Genetics (http://www.ddbj.nig.ac.jp/), accession number DRA000533.
Cluster analysis and pathway analysis
Alignment to the NCBI H. sapiens genome sequence reference assembly (hg19) detected
33,565 genes from the RefSeq transcripts (S1 Table). Of these, 18,123 genes were expressed in
mRNA extracted from U3-A cells. The expression of these genes was normalized to the
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GAPDH expression in the same sample. We then filtered for fold changes of>2 or<0.5 in Rel-
ative Expression Value (REV; expression in U3-B,-C, or—DT divided by expression in U3-A),
resulting in a set of 8,032 genes of U3-DT (S1A Fig). REV of GPC5 was the top value of all
genes in U3DT cells. Of the top 10 REV, 6 genes (GPC5, CCDC3, COL4A5, ADCY8,
CHRDL1, and PK1B) were also included in the top 10 REV of U3-C cells, but were not includ-
ed in REV of U3-B cells. Genes with REV values between 0.5 and 2 were omitted from further
analyses. Cluster and pathway analyses of the expression values of these 8,032 genes were per-
formed using the Multi Experiment Viewer (MeV) software (http://www.tm4.org/mev) and
IPA software (Ingenuity Systems, Inc., http//www.ingenuity.com/), respectively. “Diseases and
Disorder” analysis was applied to REV of 8,032 genes in U3-DT cells by the IPA software and
the most frequent result was “tumorigenesis”. Furthermore, even if 18,123 genes were analyzed
without utilizing a cut-off (0.5 to 2.0 REV), the same results were obtained. A total of 1,732
genes were analyzed, including 162 tumor-related genes identified from the literature and
1,570 genes detected by the IPA software (S1B Fig and S2 Table). We mainly classified 1,732
genes to 12 groups in accordance with information in the Gene database of NCBI.
qRT-PCR analysis using SYBR Premix EXTaq (Method A)
RNAs of U3-A (PDL 80, Stage I) or U3-DT cells (PDL 270, Stage IV) were extracted from
5 × 106 cells by the standard Trizol method using Sepasol RNAI Super G (Nacalai Tesque).
RNA was reverse transcribed by ReverTra Ace qPCR RTMaster Mix (Toyobo CO. LTD) and
the cDNA subjected to qRT-PCR in a real-time PCR instrument (Thermal Cycler Dice Real
Time Single System; Takara) with SYBR Premix EXTaq (Takara). GAPDH was used as the in-
ternal control. Primers used in the experiments were shown in (S1 Method).
siRNA treatment
U3-DT cells were seeded in 6-well tissue culture dishes (2 × 105 cells per well) and cultured in
DMEM containing 10% FBS. The following day, cells were transfected with 100 or 200 nM of
Accell Human GPC5 siRNASMARTpool or a non-targeting control siRNA [Thermo Scientif-
ic] in Accell siRNA Delivery Media containing 0.1%-FBS [Thermo Scientific] [28].
Cell proliferation assay
Cells were plated on 96-well tissue culture plates (2,000 cells per well) in 0.09 ml of DMEM
containing 0.1% FBS. The cells were then used in CCK-8 assays (Dojindo Laboratories) accord-
ing to the manufacturer’s instructions. Briefly, 10 μl of CCK-8 reagent was added to each well
and incubated at 37°C for 60 min. Cell proliferation was calculated on the indicated days by
measuring the absorbance at 450 nm. The assay was performed in quintuplicate wells and each
assay was performed at least three times.
Western blot analysis
siRNA-treated U3-DT cells were lysed in PTS buffer containing protease inhibitors and the
protein concentration of each sample was adjusted to 10 μg/8 μl. Each sample was then ana-
lyzed by Western blotting with a rabbit MAb against anti-Glypican 5 (clone ab124886; Abcam)
and HRP-linked anti-rabbit IgG-goat antibody (Cell Signaling Tech.) [29]. Colored marker
(Protein MultiColor III) was purchased from BioDynamics Laboratory Inc.
Alteration in Gene Expression on Transformation
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Cell-cycle analysis
siRNA-treated cells were suspended in 0.1% FBS containing DMEM and 5 × 103 cells per well
were cultured in a well of 98-wells plate for 5hr. Cells were treated with culture medium con-
taining 20 μM 5-ethynyl-2’-deoxyuridine (EDU) for 30 min before they were harvested. The
cells were then processed using the Click-iT plus EdU AlexaFluor 647 Imaging Kit (Invitro-
gen), stained with Hoechst 33342 and anti-Cyclin B1 rabbit IgG antibody and detected with
Alexa 488-conjugated goat anti-rabbit IgG (Invitrogen; A-11008; 1:1000). Cell-cycle profiling
of stained U3-DT cells was performed with an ImageXpress Micro (Molecular Devices).
Immunocytochemistry
Cells cultured on coverslips were washed in phosphate-buffered saline (PBS), fixed in 4% para-
formaldehyde in PBS and then blocked with 1% BSA in PBS. The cells were stained with an
anti-GPC5 antibody (R&D Systems, Inc.), or anti-Ptc1 antibody (LifeSpan BioSciences, Inc.),
and Alexa Fluor 488 or 594 labeled secondary antibody (Molecular Probes, Inc.). The cells
were then counterstained with DAPI and visualized using a fluorescence microscope (model
BZ-9000; Keyence).
Results
Phenotypic characteristics of UE6E7T-3 cell line
This laboratory has previously demonstrated that aneuploidy, specifically the loss of one copy
of chromosome 13, arises in the immortalized hMSC line UE6E7T-3 after prolonged culture
[21,22]. We wished to investigate whether continuing culture after the appearance of aneuploi-
dy would induce transformation of UE6E7T-3. To this end, we analyzed the phenotypic char-
acteristics of the cells at various PDL (Fig 1). We monitored the growth characteristics of
UE6E7T-3 cell line during long-term culture (Fig 1A). Alterations were observed in population
doubling time (DT). DT was 40 hours at initial stage (Stage 1, PDL 65) and it slightly became
longer at next stage (DT = 44, Stage II, PDL 120), and decreased to 28–22 hours afterward
more than 150 PDL (Stage III, PDL 220 and Stage IV, PDL 252). Over the course of culture
until PDL 252, UE6E7T-3 cells exhibited typical fibroblastic morphology with a uniform bipo-
lar spindle shape, and no obvious morphological changes were observed (Fig 1B). Typical
markers associated with hMSCs showed similar patterns at Stage I–IV, including markers that
are expressed in hMSCs (CD44, CD73, CD90, and CD105) and those that are not (CD34 and
CD45), although expression of CD90 and CD105 was slightly reduced at later stages (Fig 1C).
In additionally, UE6E7T-3 cells can differentiate into adipocytes and osteocytes, an important
characteristic of MSCs [21].
Changes in karyotype and neoplastic transformation during prolong
cultivation
The growth rate at PDL 252 (population doubling time (DT) of 22 hours) was 2-fold higher
than the rate at PDL 65 (DT: 40 hours). Distinct alterations in numerical and structural karyo-
types appeared as PDL increased (Fig 2A and 2B). As shown in Fig 2A, nearly 90% of the cell
population contained 46 chromosomes at PDL 62 (Stage I). By PDL 92, this proportion had de-
creased markedly to 17%, and a new population that contained 44–45 chromosomes had ap-
peared. Between PDL 92 and PDL 147 (Stage II), cells were unstable and comprised several
populations differing in karyotype: near-diploid, with 44–45 chromosomes (37–55%); diploid
(2–17%); near-tetraploid, with 83–91 chromosomes (6–30%); and several minor populations.
These populations were gradually replaced by near-tetraploid cells with 73–82 chromosomes
Alteration in Gene Expression on Transformation
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Fig 1. Phenotypic characteristics of UE6E7T-3 during long-term in vitro culture. (A) Growth curve. UE6E7T-3 cells were seeded at 5X103 cells / ml in
POWEREDBY 10. When cells were subconfluently grown, the cells were passaged with trypsin as shown in the text. After counting cell numbers, aliquot of
the cultured cells was cultured continuously. (B) Phase-contrast images of UE6E7T-3 at four stages. Scale bar, 300 μm. (C) Flow cytometry. UE6E7T-3 cells
(10,000 cells) were plotted. X-axis is fluorescence intensity. Y-axis is number of cell.
doi:10.1371/journal.pone.0126562.g001
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Fig 2. Phenotypic alterations of UE6E7T-3 during long-term culture. (A) Changes in chromosomal number at various culture stages. Chromosomes
were counted by DAPI staining of 50–80 metaphase spreads at each PDL. Distribution pattern of cells at PDL 62, 92, 118, and 147 were rearranged from raw
data from a previous report. (B) Multicolored fluorescence in situ hybridization (mFISH) karyotyping of UE6E7T-3 at three culture stages. Chromosome 13 is
circled. (C) Colony formation in soft agar at three culture stages. (D)Graphical representation of the relative colony counts (expressed as percentages) at
four culture stages. Colonies300 μm in diameter were counted. Bars represent mean numbers of colonies of triplicates (percent + s.d.).✰, p < 0.01. (E)
Hematoxylin and eosin staining of invasive sarcoma following i.m. injection of U3-DT. Scale bar, 500μm. (Boxed area is magnified in D). (F) Magnification of
transformed U3-DT in mouse muscle tissue. Dividing cells (arrow), cells containing two nuclear bodies (arrowhead), and cells containing increased chromatin
(asterisk) indicate tumorigenesis. Scale bar, 50 μm.
doi:10.1371/journal.pone.0126562.g002
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(72% at PDL 200, Stage III) and subsequently near-triploidy with 64–72 chromosomes. At fur-
ther passages (PDL 252 and PDL 295, Stage IV); the population pattern remained stable with
mostly near-triploid cells.
We next analyzed the structural karyotypes of UE6E7T-3 by mFISH. At PDL 60, cells exhib-
ited a structurally normal diploid karyotype (Fig 2B, PDL60). By contrast, at PDL 92–147 there
were several distinct populations (Fig 2B, PDL 110). Most of the near-diploid population, with
45 chromosomes, had lost one copy of chromosome 13 and one p-arm of chromosome 16
without translocations or insertions (n = 18 spreads; Fig 2B, PDL 110, left), whereas the popu-
lation with 44 chromosomes had lost an additional chromosome (most often chromosome 21
or X) (n = 17 spreads). The near-tetraploid population consistently maintained two deletions
of two copies of chromosome 13 and two p-arms of chromosome 16, with random loss of
other chromosomes (Fig 2B, PDL 110, right), but exhibited few structural rearrangements.
These results indicate that near-diploid aneuploidy arose through the loss of one or two chro-
mosomes (one of which was chromosome 13) from a diploid cell; subsequently, near-diploid
cells spontaneously became near-tetraploid via cleavage failure. After the formation of near-tet-
raploid, structural rearrangements such as translocations, insertions, and deletions occurred
frequently, e.g., the fusion of chromosome 13 and chromosome 8, and the insertion of chromo-
some 13 into chromosome 14 (Fig 2B, PDL 252). This suggests that the deletion of chromo-
some 13 (formation of near-diploid aneuploidy) induces further chromosomal instability.
Neoplastic transformation of UE6E7T-3 cell line
Transformed cells lose contact inhibition, distinguishing them from normal cells, which cannot
grow past confluence. To test the contribution of chromosomal instability (CIN) to transfor-
mation in vitro and in vivo, we examined the ability of UE6E7T-3 cells to form colonies in soft
agar and tumors in immunodeficient mice. When UE6E7T-3 at various stages were seeded in
soft agar, no anchorage-independent growth could be detected at early PDL (PDL 65 and 200),
even after 4 weeks in culture. By contrast, a considerable number of anchorage-independent
colonies were detected when PDL 252 cells were seeded in soft agar (Fig 2C and 2D). To deter-
mine whether this colony formation indicated tumorigenicity [12], cells at PDL 262 were in-
jected subcutaneously or intramuscularly into immunodeficient nude mice. Four of the six
mice injected with the PDL 262 cells formed sarcomas at the injection site after 4 weeks. Of the
three mice injected intramuscularly, all formed sarcomas, although only one of the three mice
injected subcutaneously did. Histological examination of the injected quadriceps femoris re-
vealed these tumors to be invasive sarcomas, exhibiting spindle-shaped cells characteristic of fi-
broblasts (Fig 2E and 2F, arrow head). This observation indicates that UE6E7T-3 cells had
undergone neoplastic transformation during long-term propagation in culture.
Gene expression profiling characterized at four stages of transformation
in vitro
To date, the genes studied over the course of cellular transformation have been limited to a
small number of genes encoding transcription factors (p53, E2F), cell-cycle regulators (p16,
cyclins), oncogene products (RAS, MYC), and tumor suppressors (p53, RB). However, it is
not obvious at which stage these factors act or how they play a causal role in advancing trans-
formation. To obtain a comprehensive picture of changes in gene expression related to pheno-
typic alterations, we took representative samples at four stages during the progression of
transformation (see Materials and Methods).
The expression profile from the Stage IV sample (U3-DT) was more similar to that of a
Stage III sample (U3-C) than to that of the Stage II sample, U3-B (Fig 3A and S1A Fig). This
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Fig 3. Alterations in expression of 1,732 selected genes. (A) Heat-map representation of expression of 1,732 genes from samples U3-B, U3-C, and
U3-DT (taken from cultures at Stages II, III, and IV, respectively) compared with expression level in U3-A (from Stage I). Relative expression values (REV)
from U3-A,-B,-C, and-DT are listed in S2 Table. (B) Functional classification of 1,732 genes and alterations in expression at three culture stages. All data
described in this text is shown in S2 and S3 Tables. Blue, U3-B; orange, U3-C; red, U3-DT.
doi:10.1371/journal.pone.0126562.g003
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observation suggests that important alterations in gene expression occur between Stages II and
III.
Furthermore, to distinguish the genes that are important in the progression of phenotypic
alterations from apparently random alterations, we filtered the 8,032 genes whose expression
levels changed significantly (S1A Fig) and yield a subset of 1,570 genes by the IPA analysis
(S1B and S1C Fig). The 1,732 genes (Fig 3A and S2 Table) were selected as described in Materi-
als and Methods and were classified into 12 groups on the basis of pathways and cellular func-
tion (Fig 3A and 3B, and S2 and S3 Tables). REVs in each group are indicated relative to the
control sample U3-A, which was derived from UE6E7T-3 (PDL 80) and exhibits a normal kar-
yotype, typical fibroblastic morphology, and contact inhibition. Experimental results are also
enumerated in S2 Table.
Oncogene and tumor suppressor gene expression
Genetic alterations commonly occurring in human tumors are often found in oncogenes and
tumor suppressor genes. Alterations in the expression of such genes occurred in UE6E7T-3,
and expression levels were markedly dependent on culture stage (Fig 3Ba and 3Bb). For exam-
ple, oncogenes, BMI1 andMYC, had low level expression at the early stage (Stage II), but were
strikingly enhanced after Stage III. A similar pattern was also exhibited by other oncogenes.
Tumor suppressor gene expression displayed an even more marked dependence on culture
stage. Expression levels of SFN, DBC1, RASSF2, DIRAS3, RASA4, andHIC1 were high at Stage
II, but then rapidly decreased (Fig 3Bb, and S2 and S3 Tables). The marked decrease in DBC1
(tumor suppressor gene) expression at Stages III and IV is in agreement with previous observa-
tions [30,31]. Although expression of PRDM2, PYHIN1, RBBP4, and RB1CC1 (genes encoding
activators of p53 or RB) were increased at Stages III and IV, relative expression levels of both
TP53 and RB1 in U3-C and U3-DT were similar to those in U3-A, as were those of genes such
as PTEN (Fig 3B, and S2 and S3 Tables).
DNA repair and chromosomal instability
When normal repair processes fail but apoptosis does not occur, irreparable DNA damage may
occur during mitotic recombination events. This damage can take several forms, including
double-strand breaks (DSBs) and DNA cross-linkages. In UE6E7T-3, the DNA repair process-
es appear to be constantly active at all stages, particularly at Stages III and IV, as evidenced by
expression of genes encoding many kinds of DNA polymerases (POLA1, POLE), excision re-
pair enzymes (PRKDC, RBBP8), nucleases, and checkpoint mediator proteins (BRCA1,MDC1)
(Fig 3Bc, and S2 and S3 Tables).
A number of genes required for stepwise karyotypic alteration (a major source of chromo-
some instability) were also up-regulated during culture, as were genes associated with DNA re-
pair, particularly at Stages III and IV. These included genes encoding components of the
kinetochore and centromere (NEK2, RAD21, SPC24, and STAG2), participants in chromosom-
al segregation (FOXMI, ESPL1, and PTTG1), motor proteins involved in chromosome posi-
tioning (KIF4A, KIF2C, CENPE, and CENPF), and regulators of cytokinesis (PRC1).
Overexpression ofMAD2L1 and PTTG1 (securin) has been observed in several tumor types
[32,33]. Recently, Schvartzman and colleagues demonstrated direct evidence for inhibition of
the p53 or Rb pathways leading to up-regulation ofMAD2L1, and that this up-regulation is re-
quired for generating chromosome instability [34]. Our observations of the inactivation of Rb
and p53 by HPV-16 E6/E7, generation of chromosome instability, andMAD2L1 overexpres-
sion strongly support their result. In addition, down-regulation of FRY or CENPBmay also
contribute to chromosome instability through de-regulation of chromosome alignment and
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formation of the spindle and kinetochore. All up-regulated chromosome instability genes in
UE6E7T-3 are among the 70 genes best correlated with total functional aneuploidy in several
cancer types [35].
Cell cycle
Generally, one cell cycle is completed within 20–100 hours, most of which is spent in the G1
phase [36]. Mechanisms regulating the cell cycle are common to all cells and are driven by
three types of factors: cyclin-dependent kinases (CDK), cyclins, and cyclin-dependent kinase
inhibitors (CKI). As shown in Fig 3Be, and S2 and S3 Tables, CDK-related genes (CDC25C,
CDK2, CDK4, CDC2L6, CDC2, and CDK2AP2) and cyclin genes (CCND2, CCNE2, and
CCNB1) were up-regulated at all culture stages, whereas CKI-encoding genes such as CDKNIC
(p57), CDKN2B (p15), CDKNIA (p21), CDKN2A (p16), and CDK2AP1 were down-regulated
at all stages. These alterations in cell-cycle gene expression resulted in an uncontrolled increase
in proliferation. Gene expression profiles at four stages of culture (PDL 80, 110, 219, and 270)
are shown in Fig 4. As a control, we used U3-A (PDL 80). Marked differences in gene expres-
sion patterns between U3-B and U3-C were observed. In U3-C (Stage III), we also observed
high expression ofMYC,MYBL2 (CDK-activating gene), BMI1 (p16-suppressing gene), CIZ1
Fig 4. Gene expression in the cell-cycle pathway during long-term culture of UE6E7T-3. U3-A, U3-B, U3-C, and U3-DT are samples from culture
Stages I, II, III, and IV, respectively. Changes in gene expression relative to the level in U3-A (Stage I) are shown. Red characters, up-regulated; purple
characters, down-regulated; black characters, U3-A (control) level; Blue fill, negative regulator. Genes with REV >2 or <0.5 are indicated as up- or down-
regulated, respectively.
doi:10.1371/journal.pone.0126562.g004
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(p21-inhibiting gene, [37]), and ATAD2 (cofactor gene of MYC) [38], in addition to increased
gene-expression of CDKs and cyclins. These changes were concomitant with a strong depres-
sion of CKI-encoding gene expression. Together, these observations suggest that these alter-
ations play a crucial role in rapid proliferation.
E2F1, which encodes a transcriptional activator, was also expressed at higher levels at late
stages. The expression of E2F1 is intimately regulated by RB. Functional inactivation of the RB
pathway in this cell line leads to E2F1 overexpression, which may be correlated with rapid cell
proliferation. Another factor contributing to the higher rate of proliferation is the functional
loss of p53 checkpoint pathways. Together, these alterations explain the decrease in U3-C dou-
bling time, which dropped to 28 hours from 44 hours in U3-B.
Apoptosis
Resistance to apoptosis is one of the hallmarks of cancer. At Stage II, apoptosis-inducing genes
such as TNFRSF11B and CASP10 were expressed at high levels, but as in the case of tumor sup-
pressor genes, expression rapidly decreased. By contrast, expression of apoptosis-suppressing
genes (TNFRSF6B, BCL2, etc.) was enhanced at later stages (Fig 3Bf, and S2 and S3 Tables).
Signaling pathways and growth factors
Extracellular signaling molecules, such as growth factors, activate specific receptors on the tar-
get cell membrane, activating second messengers, and eventually elicit a physiological response.
As shown in Fig 3Bg, and S2 and S3 Tables, striking alterations in gene expression were ob-
served only in the Hedgehog (Hh) signaling pathway (DHH, PTCH1, SMO, and GLI1); howev-
er, some of these genes were down-regulated at later stages. By contrast, genes encoding Wnt
signaling factors (FZD1,WNT5A, APC, and CTNNB1) are not likely to be implicated in the
transformation of UE6E7T-3 cells.
Unregulated expression of growth factors, cytokines, receptors, and signaling components is
linked to developmental abnormalities and a variety of chronic diseases, including cancer. In
UE6E7T-3, such genes were considerably up-regulated, especially at later stages (Fig 3Bh, and
S2 and S3 Tables). The expression levels of IGF2BP2, RAI2, SLC25A27, NCBP2, and EIF4B
were greatly enhanced, as is the case in tumor development. TFRC, a marker of human pancre-
atic cancer [39], was also expressed at a high level, as was F2R, which encodes a G-protein-cou-
pled receptor. By contrast, expression levels of genes encoding chemokines or interleukins and
their receptors were undetectable.
Lineage markers and adhesion-associated genes
Genes encoding markers of mesenchymal cells (CD44, CD73, CD90, and CD105) were ex-
pressed in U3-DT at levels similar to those in U3-A (Fig 1C). Tumor-marker genes (HMGA2,
TPD52, and GPC5) were overexpressed in U3-C and U3-DT (Fig 3Bi, and S2 and S3 Tables).
U3-A has the potential to differentiate into several types of cell, including adipocytes and osteo-
blasts [21]. Gene expression of markers characteristic of these cell types was down-regulated in
U3-DT cells (ACTA2,MSX2, CNN1, TAGLN, LMOD1, and POSTN).
Expression of adhesion-related genes was strongly suppressed in U3-C and U3-DT, with
the exception of COL4A5, a member of the collagen family (Fig 3Bj, and S2 and S3 Tables). E-
cadherin (product of CDH1) is one of the most important molecules in cell-cell adhesion in ep-
ithelial tissue. CDH1 expression was markedly reduced in U3-C (Fig 3Bj, and S2 and S3 Ta-
bles). Suppression of CDH1 expression is one of the primary molecular events responsible for
dysfunction in cell-cell adhesion, such as that which occurs in tumor progression. On the other
hand, N-cadherin (CDH2) expression remained high. Other adhesion molecules were also
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expressed at low levels comparable to those in U3-A, as observed in tumor cells. Expression
levels of integrins, receptors that mediate attachment of cells to extracellular components such
as collagen and fibronectin, were normal; however, collagen expression reduced considerably
with tumorigenic progression. These results suggest that reduced expression of these adhesion
molecules plays an important part in promoting invasion into surrounding stroma.
Angiogenesis, invasion, and metastasis
Oxygen and nutrients supplied by vasculature are crucial for cell function and survival. Beyond
a certain size, tumors induce blood vessel growth (angiogenesis) by secreting various growth
factors, thereby allowing the tumor to obtain oxygen and essential nutrients in vivo. In
UE6E7T-3, genes encoding major contributors to angiogenesis (TEK, VEGFC, FGF2, and
ANGPT1) were expressed at remarkably low levels, although the expression of genes encoding
their receptors (KDR, FLT1) was high (Fig 3Bk, and S2 and S3 Tables). Another major contrib-
utor to angiogenesis is matrix metalloproteinase (MMP1, MMP2, MMP3, and MMP14). These
proteases were also expressed at low levels, as were the MMP inhibitors (TIMP1, TIMP3, and
TIMP4) (Fig 3Bl, and S2 and S3 Tables).
Similar low levels of expression were observed in invasion- and metastasis-related genes.
Cell-cell and cell-matrix adhesion molecules play an important role in cell migration. E-cad-
herin, which is considered an important suppressor of invasion and metastasis, rapidly de-
creased in gene expression at Stage III (Fig 3Bj, and S2 and S3 Tables). This reduction is likely
to represent a key step in the acquisition of invasive properties. Furthermore, integrin family
genes (ICAM1, ICAM2, ICAM5, and VCAM1) were also expressed at low levels (Fig 3Bj, and
S2 and S3 Tables). These results suggest that even U3-DT may still be in the earliest stages of
tumorigenesis. Alternatively, in terms of angiogenesis-, invasion- and metastasis-related gene
expression, tumorigenesis in fibroblastic cells may differ from that of epithelial cells.
Validation of RNA-Seq
To evaluate of RNA-Seq analysis, we chose 29 genes at Stage IV in each pathway identified by
RNA-Seq for qRT-PCR analysis (Fig 5). The expression pattern of the genes determined by
qRT-PCR analysis is similar to the results of RNA-Seq analysis, although slight differences in
expression level were detected between two methods. In addition, to confirm the accuracy of
RNA-Seq data we compared the expression levels of 41 samples according to RNA-Seq and
qRT-PCR analyses, including 29 genes at Stage IV analyzed by Method A and 4 genes at Stage
II-IV analyzed by Method B (S1 Method), and obtained a high concordance (Spearman’s rank
correlation coefficient, R = 0.76) between these two sets of data (S1 Method and S1 Fig). A coef-
ficient of 0.76 corresponds to a significance level of slight less than 0.1%. This indicated that
our RNA-Seq could reliably measure gene expression differences.
GPC5 expression affects UE6E7T-3 cell proliferation
A unique pattern of gene expression was observed in UE6E7T-3 cells; GPC5 was overexpressed
at the late stage of long-term culture. To assess whether this overexpression affected the prolif-
eration in U3-DT cells, we examined the effect of GPC5 knockdown. Knockdown of GPC5 by
GPC5 siRNA (SMARTpool siRNA) was confirmed by Western blot analysis (Fig 6A), and re-
sulted in significant inhibition of proliferation of U3-DT cells compared with that in cells in-
fected with control non-target siRNA (Fig 6B). These results show that overexpression of
GPC5 stimulates the proliferation of U3-DT cells.
The proliferation rate of cells treated with target-specific siRNAs was comparable to the rate
of cells treated with a non-targeting siRNA control, but the growth curve had lag phase at the
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initial stage (Fig 6B). To examine which phase in the cell cycle is affected by the target-specific
siRNA, we used an ImageXpressMicro analyzer (Molecular Devices). As shown in Fig 6C,
treatment with specific siRNAs resulted in an increase of cell numbers in G1 phase and slight
decreases in S, G2 and M phases, indicating that the decreased proliferation induced by siRNA
is due to the retention of cells in G1. Cell-cycle distribution analysis did not reveal any cells in
the sub-G1 phase following siRNA treatment and we did not observe any cells with apoptotic
morphology.
Li et al. [28] reported recently that GPC5 localizes to the primary cilium in rhabdomyosar-
coma (RMS) cells and promotes cell proliferation by binding to Ptc1, the cell-surface receptor
for Hh signaling. Our RNA-Seq and qRT-PCR analyses showed that Ptc1 is significantly upre-
gulated in U3-DT cells. Therefore, to investigate the interaction between GPC5 and Ptc1, we
examined the localization of endogenous GPC5 and Ptc1 in U3-DT cells with antibodies
against GPC5 and Ptc1. Although both GPC5 and Ptc1 antibodies weakly and diffusely stained
U3-A cells (data not shown), strong staining of GPC5 was detected at the same region of con-
centrated Ptc1 staining (Fig 6D). This fluorescence staining pattern is similar to the endoge-
nous localization of GPC5 in the cilia of RMS cells [28] and of Ptc1 in the cilia of NIH 3T3 cells
[40]. This finding suggests that GPC5 interacts with components of the Hh signaling pathway.
Discussion
This study shows that the hMSC line, UE6E7T-3, immortalized with the hTERT gene in combi-
nation with the HPV-16 E6/E7 genes, gradually transformed during prolonged culture. The
HPV-16 E6/E7 gene products, the E6 and E7 proteins, abrogate repression of the cell cycle
through their associations with p53 and pRb, respectively [41]. In parallel with acquisition of
increased tumorigenicity, numerous alterations in gene expression occurred spontaneously
with culture passage. These alterations are similar to previous data, which MSCs derived from
p21-/-p53+/-mice completely lost p53 expression after in vitro long-term culture and formed
sarcomas in vivo [42] and muline MSCs derived osteosarcoma cells in consequence of aneu-
ploidization and genomic loss of Cdkn2 [43]. Our comprehensive gene expression analysis
Fig 5. Comparison of RNA-Seq and qRT-PCR.Results of qRT-PCR analysis of remarkable genes at Stage IV are shown as the relative expression ratio
(blue) compared to those of the RNA-Seq analysis with whole transcriptome sequencing (red). Bar, standard error.
doi:10.1371/journal.pone.0126562.g005
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provided several important pieces of evidence regarding transformation-related changes at dif-
ferent stages of prolonged culture. A summary of the alterations in cytological features and
gene expression over the course of the transformation process is shown in Table 1.
First, we demonstrated that only mitotically defective near-triploid cells (U3-DT), present
in a mixed cell population exhibiting chromosome instability (CIN), contributed to the tumori-
genicity of UE6E7T-3 cells; however, tumors formed at 66% of injection sites, so, therefore, ad-
ditional genetic alterations may be necessary for U3-DT cell tumorigenesis. The contribution
of polyploidy cells to tumorigenesis has been demonstrated in other studies. Tetraploidy can
promote CIN and tumorigenesis in p53-null mouse mammary epithelial cells [44] and in Pim-
1-expressing human prostate and mammary epithelial cells [45]. U3-A cells with microsatellite
Fig 6. GPC5 expression affects proliferation in U3-DT cells. (A) Western blot analysis. Cells were treated with siRNA for 3 days. Cells were lysed and the
levels of GPC5 were examined by Western blotting with anti-GPC5 Rabbit mAb. Lane 1, control siRNA-treated cells; Lane 2, GPC5 siRNA-treated cells;
Lane 3, markers. (B) Growth curve. siRNA-treated cells (2,000 cells/well) were then seeded in 96-well culture plates and proliferation was assessed by CCK-
8 assay at the indicated time points. An exponential approximation line of control (blue) or siRNA-treated (red) dots was drown between for 14 to 86hr. The
results are expressed as the mean ± S.D. of quintuplicate wells. P < 0.05. (C) Cell-cycle distribution of U3-DT cells. Cell cycle distribution (%) of U3-DT cells
incubated in medium containing siRNA (red) or not (blue) is shown. (D) Immunofluorescence profile of U3-DT cells. Double immunofluorescence labeling
with anti-human GPC5 (red) and Ptc1 (green) antibodies in U3-DT cells. Nuclei are labeled with DAPI (merged image). Arrows: GPC5 and Ptc1 positive-
merged spots (yellow) are clearly visible in U3-DT cells. Scale bar = 50 μm.
doi:10.1371/journal.pone.0126562.g006
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instability in chromosome 13 have a diploid karyotype during the first 90 PDL, and they prefer-
entially lose one copy of chromosome 13 upon prolonged culture [22]. The loss of a whole
chromosome 13, even a single copy, causes significant damage to near-diploid cells, but some
survive (i.e., are selected), subsequently, acquire additional aneuploidy and tumor-related gene
expression. Finally, unstable triploidy confers tumorigenicity and is a dominant feature of tu-
mors. This karyotypic heterogeneity of genomes is consistent with the neoplastic progression
theory [46], which holds that tumorigenesis occurs by a complex evolutionary process: accord-
ing to this theory, progression develops as genetic instability is acquired, leading to the accu-
mulation of genetic alterations and the continual selective outgrowth of variant subpopulations
of tumor cells with a proliferative advantage.
By contrast, despite having a normal diploid karyotype with no detectable chromosome ab-
normalities, hTERT-transduced adult human MSCs (hTERT20) formed tumors after long-
term culture [47]; however, these cells exhibit deletion of the Ink4a/ARF locus and epigenetic
silencing of DBCCR1. A similar phenomenon was reported in hTERT-immortalized human fi-
broblast cell lines (WI-38, Leiden), which have a diploid karyotype and in which Ink4a is delet-
ed [48,49]; however, these cell lines require active H-Ras or H-Ras and inactive p53 for tumor
formation, resulting in the acquirement of chromosome abnormalities. Therefore, these reports
suggest that h-TERT-mediated immortalization does not significantly affect genome integrity
at the chromosome level, and that h-TERT-associated genetic and/or epigenetic alterations
contribute to tumorigenicity rather than karyotype alterations. In addition, the genetic and/or
epigenetic alterations may largely reflect differences in the pre-existing genetic makeup of each
strain and the culture conditions.
Secondly, we showed that UE6E7T-3 acquired properties of transformed cells even without
RAS- andMYC-mediated transduction. However, this transformation had a long latency,
Table 1. Summary of cellular and genetic characteristics of UE6E7T-3 cells at four stages of transformation.
Stage I II III IV
PDL 60–90 91–150 151–230 231–295
Ploidy diploid aneuploid mix polyploid near-triploid
Number of chromosome (mode) 46 45 88 68
Cell shape F F F F
Doubling time (hr) 40 44 28 22
Growth in soft agar negative negative slight positive
Growth in mouse NT NT NT sarcoma
Oncogene control C +++ +++
Tumor suppressor gene control +++ - -
DNA repair gene (NHEJ) control + +++ +++
CIN gene control ++ +++ +++
Cell cycle activator control ++ ++ ++
Cell cycle suppressor control +/- - -
Apoptosis activator control +++ - -
Apoptosis inhibitor control C ++ +++
Growth factor, Signal transduction control + +++ +++
Adhesion-related gene control ++ - -
Angiogenesis, Invasion, Metastasis control +/- +/- +/-
Note: (+), (-) and (C) denote the up-regulated, down-regulated, or control-level expression of major genes shown in Fig 3B. F, fibroblastic-like; NT,
not tested.
doi:10.1371/journal.pone.0126562.t001
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requiring continuous in vitro passages. Significant overexpression of RAS was not detected at
any stage of prolonged culture, suggesting that, at least for UE6E7T-3, the RAS pathway is not
critical in transformation. This result is consistent with those of two previous studies [18,50],
in contrast to other reports that RAS activation is an essential requirement for transformation
[2–10]. We did, however, observe the marked up-regulation of other oncogenes (BMI1, STAC,
MYC, PIK3CA, RRAS2, and ATAD2) in Stages III and IV. From these results, we infer that al-
ternative pathways or currently unidentified factors may exist, which influence transformation
in long-term culture.
Thirdly, we clearly demonstrated that numerous alterations in gene expression, in multiple
pathways related to the acquisition of increased tumorigenicity, occurred spontaneously over
prolonged culture. Our analysis of gene expression identified a crucial stage (Stage III), involv-
ing drastic changes in multiple pathways that determines the fate of UE6E7T-3 (Table 1).
These changes included high expression of oncogenes as well as genes related to DNA-damage
repair, chromosome instability, cell-cycle activation, inhibition of apoptosis, and increase of
growth factors, concomitant with a strong depression of genes involved in tumor suppression,
apoptosis, and adhesion. In particular, the suddenly increased expression ofMYC, BMI1,
GPC5, and CIZ1 at this stage suggests that these genes play a key role in converting UE6E7T-3
to a tumorigenic state. BMI1 encodes a key regulator in several cellular processes, including
normal stem cell renewal and cancer cell proliferation [51]. The high expression of BMI1 in
U3-C and U3-DT suggests that these cells are tumorigenic. The main target of BMI1 is the
INK4A locus, which encodes two structurally distinct proteins, p16INK4a and p14ARF, both of
which play important roles in cell-cycle regulation. In UE6E7T-3, up-regulation of BMI1 could
result in low CDKN2A (p16INK4a-encoding gene) expression, allowing increased transcription
of E2F, which would in turn lead to increased proliferation. ATAD2 and CIZ1, which were also
expressed at high levels in the late stages, are also highly expressed in a significant proportion
of human tumors [38,52], suggesting that these genes contribute to proliferation, ultimately
leading to transformation. Similar patterns were observed for apoptosis inhibitors and apopto-
sis accelerators (Fig 3Bf, and S2 and S3 Tables). When DNA damage is too extensive, check-
point pathways trigger apoptosis. However, Stage III cells (U3-C) exhibited decreased
expression of apoptosis-inducing genes and increased expression of anti-apoptotic genes.
These cells failed to undergo apoptosis; the resulting spontaneous survivors (U3-DT) are dis-
tinct from U3-A and U3-B. Mutations arising from unrepaired DNA damage in normal
human cells are prevented by the p53 and pRB checkpoint pathways, resulting in DNA repair,
apoptosis, or senescence. Normal cells stop dividing until they have completed repair to their
DNA. By contrast, genetically unstable UE6E7T-3 cells with defective DNA can easily avoid
checkpoints due to breaks in their checkpoint pathways, and thereby maintain a higher rate of
proliferation than normal cells. Such cells induce subsequent mutations by repetitive mitosis,
over the course of which missegregation of whole chromosomes generates
additional aneuploidy.
Similarly, expression of E-cadherin, a known tumor suppressor in many cancers [53,54],
rapidly dropped at Stage III (Fig 3Bj, and S2 and S3 Tables). This shutdown was concomitant
with the repression of expression of other adhesion genes, resulting in reduced cell-cell or cell-
extracellular matrix interactions, suggestive of an invasive tendency. However, MMPs, which
help to degrade extracellular matrix proteins, were expressed at lower levels in U3-C and
U3-DT (Fig 3Bl, and S2 and S3 Tables). In addition, VEGFC, which along with MMPs is a
major contributor to angiogenesis, was also expressed at low levels in U3-DT. VEGFC causes a
signaling cascade resulting in maturation of endothelial cells into blood vessels. The low
VEGFC expression suggests that cascade members downstream, including MMPs, VCAMs,
and ICAMs, would not be stimulated, and U3-DT cells may be promoted with respect to
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malignancy in future. Together, these alterations in gene expression in different core pathways
strongly suggest that the transition of UE6E7T-3 into a tumorigenic state occurred at Stage III,
concomitant with drastic alterations in chromosomal numbers and chromosomal structures.
At the same time, expression of genes encoding tumor markers rose dramatically at this stage,
and the cells acquired defects in their ability to differentiate into several lineages.
Finally, from this comprehensive genetic analyses, we identified molecular signatures in
U3-DT that are commonly expressed in various types of tumors, as mentioned above, suggest-
ing that transformants of many cell types show common signature in gene expression.
In addition, one important finding in this study pertains to the glypican-5-gene (GPC5)-re-
lated signaling. GPC5, which is a sarcoma cell marker [55], was markedly overexpressed at
later culture stage in association with transformation of UE6E7T-3 cells. Other studies recently
showed that GPC5 stimulates the proliferation of rhabdomyosarcoma (RMS) cells [28] and
lung metastatic cells in salivary adenoid cystic carcinoma [56], while GPC5 may be a tumor
suppressor in non-small cell lung cancer [57]. We have shown here that GPC5 augmented cell
proliferation in UE6E7T-3 cell line (Fig 6). GPC5 encodes one of the six members of the glypi-
can family (GPC1 to GPC6), heparan sulfate proteoglycans, which serve as essential modula-
tors of key regulatory proteins such as Wnt, FGF, and Hh [58–60]. Li, et al. demonstrated that
GPC5 acts as an activator of Hh signaling in RMS cell proliferation [28], whereas these authors
have previously reported that GPC3 acts as an inhibitor of the same signaling in mouse embryo
[61]. This indicates that two members of glypican family can display opposite roles in the regu-
lation of Hh signaling. In UE6E7T-3 cell line, GPC3 is little expressed (S1 Table). In addition
of marked overexpression of GPC5, a high level of expression of Hh signaling components
(DHH, PTCH, and GLI1) was also found in U3-DT cells. Furthermore, DKK3, an inhibitor of
the Wnt signaling, was overexpressed in U3-DT.
Based on these results, we propose that GPC5 stimulates the proliferation of U3-DT
through the Hh signaling pathway by stabilizing the interaction between ligands and receptors.
In human cerebellar granule cells, BMI1 expression is up-regulated in response to sonic Hh
protein (product of SHH) and parallels expression of GLI1 [62]. GLI1 overexpression induces
BMI1 expression, implying that BMI1 is a downstream target in the Hh signaling pathway, and
that its activation promotes cell proliferation by suppressing p16INK4A. Therefore, GPC5may
inhibit the Wnt signaling pathway and may also play an important role in the rapid prolifera-
tion of U3-DT at late stages, by regulating BMI1 via the Hh signaling pathway. The possibility
must be elucidated by future studies.
Expression of the BCL11A, IL17REL, and CCDC3 genes was markedly elevated at Stage IV.
Although BCL11A is an essential regulator of normal lymphocyte development in mouse em-
bryos [63] and its expression is elevated in some lymphoma patients [64], the mechanism un-
derlying this is unknown. The elevated expression of these genes suggests that they function in
the tumorigenesis of U3-DT cells. In the future, we aim to clarify the functions of these genes
in U3-DT cell tumorigenesis.
The results obtained in this study suggest that the UE6E7T-3 cell line can be used as a cul-
ture model for neoplastic transformation associated with dynamic alterations in gene expres-
sion and karyotype. Thus, this model may be a useful tool for assessing the functional
contribution of genes showed by expression profiling to neoplastic transformation.
The cell lines generated in this study, each of which is characteristic of a particular stage in
the transformation process, could have wider applications. U3-DT may prove useful for screen-
ing anticancer drugs, such as CtIP inhibitors, and U3-B might be useful for investigating the
mechanisms of genetic aberration associated with neoplastic transformation or tumorigenesis.
Furthermore, GPC5 might be a biomarker for sarcoma of human cells.
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Supporting Information
S1 Method. Estimation of gene expression values by qRT-PCR. The qRT-PCR was per-
formed by two methods.
(PDF)
S1 Fig. Cluster and pathway analyses of 8,032 genes expressed in U3-B,-C, and-DT. Cluster
analysis of 8,032 genes performed using MeV software (A) and ‘Diseases and Disorders’ analy-
sis using IPA software (B). The ‘Diseases and Disorders’ analysis revealed that 1,570 genes had
expression patterns in U3-B, U3-C, and U3-DT that were characteristic of ‘Cancer’ (p-value,
1.92E-21), within which the ‘Function’ characteristics pinpointed ‘Tumorigenesis’ (C).
(TIF)
S2 Fig. Correlation between the qRT-PCR and the RNA-Seq data. (A) Relative expression
values estimated by qRT-PCR or RNA-Seq. To validate the relative expression values generated
by RNA-Seq, the relative expression values of 41 samples with 33 selected genes were calculated
from qRT-PCR and RNA-Seq data. The correlation between two values was then verified sta-
tistically. (B) Correlation between the relative expression ratios calculated from the qRT-PCR
and RNA-Seq data. The relative expression values of 41 samples calculated from qRT-PCR and
RNA-Seq were plotted on the X-axis and Y-axis, respectively. Spearman’s rank correlation co-
efficient, (R) was calculated in accordance with a formula described in Method B (S1 Method).
(TIF)
S1 Table. Gene expression value of 33,565 genes in U3-A, U3-B, U3-C, and U3-DT cells.
(PDF)
S2 Table. The relative expression value (REV) of 1,732 genes shown in Fig 3A. Expression
value of U3-A,-B,-C, and-DT is the expression level of each gene divided by the level of
GAPDH expression in the same sample. () Expression values for U3-A were obtained by di-
viding the value of each gene by that of GAPDH of U3-A, and then multiplying by 1,000. ()
REV of each gene in U3-A,-B,-C, and-DT is the expression level in U3-B,-C, or—DT divided
by the expression level in U3-A.
(PDF)
S3 Table. List of genes shown in Fig 3B.Of the 1,732 genes listed in S1 Table, gene symbols
and function of 180 genes (Fig 3B) are shown, in general, according to the NCBI gene database.
(PDF)
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